Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $96.87 Analyst target: $156.17 Upside: 61.22%
Oruka Therapeutics, Inc. is a biotechnology company.
See the full interactive analysis & chart →Informational only — not investment advice.